Vivo Bio Tech Limited is an India-based company, which is a comprehensive preclinical clinical research organization (CRO) serving pharmaceutical and biotech firms. It operates in the biotechnology segment. It provides integrated discovery, development & regulatory services to pharmaceutical, agrochemical, industrial chemical, vaccines, nutraceutical & medical device companies. The Company's services include in-Vivo and in-Vitro toxicity studies, pharmacological investigations, pharmacokinetic, toxicokinetic studies, genotoxicity screening and analytical services. It screens and assesses molecules for diverse pharmacological properties. In oncology, it designs syngeneic/xenograft models for anti-cancer agent evaluation. It customizes in-Vivo DMPK studies for rodent and non-rodent models to profile drug candidates. It provides both regulatory and non-regulatory IND-enabling preclinical development services. As of 15 Jun 2026, VIVO BIO TECH LTD. share price is ₹23.77. The stock opened at ₹23.90, compared to its previous close of ₹23.04. During today's trading session, VIVO BIO TECH LTD. share price moved in the range of ₹23.00 to ₹23.95, with an average price of ₹23.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹23.00 and a high of ₹23.95.
The market capitalization of VIVO BIO TECH LTD. is ₹53 Crs, with a P/E ratio of -30.9 and a dividend yield of 0.00%.